Option Care Health Inc (OPCH) saw its stock price plummet by 9.80% in pre-market trading on Thursday, despite reporting better-than-expected third-quarter results. The sharp decline appears to be driven by the company's full-year 2025 guidance, which fell short of some investor expectations.

For the third quarter ended September 30, 2025, Option Care Health reported strong financial results. The company's revenue reached $1.435 billion, up 12.2% year-over-year and surpassing the analyst consensus of $1.412 billion. Adjusted earnings per share (EPS) came in at $0.45, beating the estimated $0.42, while adjusted EBITDA for the quarter was $119.5 million, also exceeding the expected $118.4 million.

However, the company's outlook for the full year 2025 seems to have disappointed investors. Option Care Health expects net revenue between $5.60 billion and $5.65 billion, which is in line with current estimates. The adjusted EPS guidance of $1.68 to $1.72 also aligns with the consensus. Despite meeting expectations, the guidance may not have been strong enough to justify the stock's recent valuation, leading to the significant sell-off. Additionally, the company's projected adjusted EBITDA of $468 million to $473 million for 2025 might have fallen short of some investors' more optimistic projections, contributing to the negative sentiment in pre-market trading.